Target intelligence / Profile preview

Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 (ELFN1)

Target
ELFN1
Molecular classification
Cell adhesion molecule (synaptic adhesion protein), Protein phosphatase regulatory subunit, Leucine-rich repeat (LRR) superfamily member, Fibronectin type III domain protein
01

Overview

Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 (ELFN1) is a postsynaptic adhesion molecule predominantly expressed in the nervous system, notably in the cortex, hippocampus, and globus pallidus. ELFN1 contains an extracellular domain with six leucine-rich repeats (LRRs), a fibronectin type-III (FN3) domain, a transmembrane domain, and an extended intracellular segment. Functionally, ELFN1 plays an integral role at excitatory synapses onto certain interneurons, modulating the timing and probability of neurotransmitter release by organizing presynaptic group III metabotropic glutamate receptors (mGluRs) in a trans-synaptic manner, acting as an allosteric modulator of these receptors. ELFN1 also inhibits the activity of protein phosphatase 1 (PP1) complexes, directly impacting synaptic circuit dynamics and potentially overall neural plasticity. Mutations or dysregulation of ELFN1 have been implicated in neurological disorders such as Joubert syndrome 17 and other synaptopathies.

Other names
ELFN1Protein ELFN1PPP1R28Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1Protein phosphatase 1 regulatory subunit 28Extracellular leucine-rich repeat and fibronectin type III containing 1
02

Mechanism of action

Allosteric modulation of group III metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7, mGluR8); Synaptic adhesion and modulation of presynaptic neurotransmitter release probability; Inhibition of protein phosphatase 1 complexes

03

Biological functions

Postsynaptic modulation of synaptic circuit dynamicsRegulation of interneuron recruitment timingInhibition of protein phosphatase 1 (PP1) complexesSynapse organization, assembly, and plasticityCell adhesion at synapsesRecruitment and allosteric modulation of group III metabotropic glutamate receptors (mGluRs)Involvement in neurite outgrowth, axon guidance, and synapse formation
04

Disease associations

Neurological diseases (including those associated with ELFN1 mutations)Joubert syndrome 17MHC class I deficiency
05

Safety considerations

Perturbations or mutations could potentially impact synaptic transmission and neurological development

Beyond the preview

Go deeper on Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 (ELFN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1 (ELFN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call